<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Instructions for Use-Patient Labeling for Human Prescription Drug and Biological Products-Content and Format; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Instructions for Use-Patient Labeling for Human Prescription Drug and Biological Products-Content and Format; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2022-07-15 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Instructions for Use--Patient Labeling for Human Prescription Drug and Biological Products--Content and Format." This guidance provides recommendations for developing the content and format of an Instructions for Use (IFU) document for human prescription drug and biological products, as well as drug-led or biologic-led combination products submitted under a new drug applicat...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-15161</p>
    <p><strong>Publication Date:</strong> 2022-07-15</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/07/15/2022-15161/instructions-for-use-patient-labeling-for-human-prescription-drug-and-biological-products-content">https://www.federalregister.gov/documents/2022/07/15/2022-15161/instructions-for-use-patient-labeling-for-human-prescription-drug-and-biological-products-content</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-15161</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
